We are live on ! Find out more
FMI

Foundation Medicine, Inc.
FMI

Delisted

FMI was delisted on the 30th of July, 2018.

127 hedge funds and large institutions have $784M invested in Foundation Medicine, Inc. in 2017 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 30 increasing their positions, 33 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

282% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 11

177% more call options, than puts

Call options by funds: $40.6M | Put options by funds: $14.7M

65% more capital invested

Capital invested by funds: $476M → $784M (+$307M)

31% more funds holding

Funds holding: 97127 (+30)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

9% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 33

Holders
127
Holders Change
+30
Holders Change %
+30.93%
% of All Funds
2.88%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
42
Increased
30
Reduced
33
Closed
11
Calls
$40.6M
Puts
$14.7M
Net Calls
+$25.9M
Net Calls Change
+$10.3M
Name Holding Trade Value Shares
Change
Change in
Stake
PC
26
Pier Capital
Connecticut
$4.91M -$3.56M -68,610 -49%
Charles Schwab
27
Charles Schwab
California
$4.74M +$336K +6,474 +10%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$4.55M +$56.1K +1,081 +2%
NIM
29
Needham Investment Management
New York
$3.92M
PIM
30
Platinum Investment Management
Australia
$3.61M -$1.96M -37,800 -42%
Morgan Stanley
31
Morgan Stanley
New York
$3.42M +$1.04M +20,082 +67%
BCPEM
32
Bain Capital Public Equity Management
Massachusetts
$3.09M +$2.35M +45,350 New
WT
33
Whittier Trust
California
$3.05M +$37.6K +725 +2%
Goldman Sachs
34
Goldman Sachs
New York
$2.6M +$52.8K +1,019 +3%
Two Sigma Investments
35
Two Sigma Investments
New York
$2.44M +$1.86M +35,824 New
TCIM
36
TIAA CREF Investment Management
New York
$2.32M -$177K -3,412 -9%
Wolverine Trading
37
Wolverine Trading
Illinois
$2.24M +$1.71M +32,896 New
Deutsche Bank
38
Deutsche Bank
Germany
$2.22M -$85.1K -1,641 -5%
ERSOT
39
Employees Retirement System of Texas
Texas
$2.11M -$674K -13,000 -30%
First Trust Advisors
40
First Trust Advisors
Illinois
$1.94M +$1.47M +28,432 New
TA
41
Teachers Advisors
New York
$1.8M
Millennium Management
42
Millennium Management
New York
$1.78M +$1.35M +26,056 New
Bank of America
43
Bank of America
North Carolina
$1.77M -$51.1K -985 -4%
ARTA
44
A.R.T. Advisors
New York
$1.77M +$1.35M +26,005 New
Swiss National Bank
45
Swiss National Bank
Switzerland
$1.69M
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$1.56M -$26.8K -516 -2%
Wells Fargo
47
Wells Fargo
California
$1.52M +$275K +5,310 +31%
ProShare Advisors
48
ProShare Advisors
Maryland
$1.48M +$20.5K +396 +2%
CS
49
Credit Suisse
Switzerland
$1.39M +$13.2K +255 +1%
CM
50
Castleark Management
Illinois
$1.33M +$1.01M +19,540 New

FMI Hedge Fund Activity: Q4 2017 in Review

127 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Foundation Medicine, Inc. (FMI) for Q4 2017, worth a combined $784M — up 65% from $476M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new FMI positions and 11 closed out — a net gain of 31 holders — while 30 added to existing stakes and 33 trimmed.

The largest buyer was Hitchwood Capital Management, opening a new position worth an estimated $18.7M. The largest seller was AllianceBernstein, cutting an estimated $19.1M.

  • 127 institutional investors held Foundation Medicine, Inc. (FMI) as of Q4 2017, up from 97 in Q3 2017.
  • Funds reported $784M of Foundation Medicine, Inc. stock for Q4 2017, up 65% quarter-over-quarter.
  • 42 funds opened new Foundation Medicine, Inc. positions in Q4 2017 and 11 closed out, a net change of +31 holders.
  • The largest Foundation Medicine, Inc. buyer in Q4 2017 was Hitchwood Capital Management, an estimated $18.7M added.
  • The largest Foundation Medicine, Inc. seller in Q4 2017 was AllianceBernstein, an estimated $19.1M sold.

Based on aggregated 13F filings for Q4 2017.